X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet   (SUNP)

Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 505.4
Mkt Cap Rs m 1,216,373
Vol '000 127.6
P/E X 43.6
P/CF X 13.4
EPS (TTM) Rs 11.6
% ch % -0.7
No. of shares m 2,406.75
% ch week % -1.5
% ch 1-mth % -0.7
% ch 12-mth % -22.9
52 week H/L Rs 659.9/433.2
(As on Apr 20, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs8486531,0741,201842 
Low Rs554493570706572 
Sales per share (Unadj.) Rs109.177.6132.3118.4131.6 
Earnings per share (Unadj.) Rs28.815.221.923.532.7 
Diluted earnings per shareRs12.413.118.923.532.6 
Cash flow per share (Unadj.) Rs32.117.127.727.838.0 
Dividends per share (Unadj.) Rs5.001.503.001.003.50 
Adj. dividends per shareRs2.151.292.581.003.49 
Dividend yield (eoy) %0.70.30.40.10.5 
Book value per share (Unadj.) Rs144.789.4135.2137.1152.7 
Adj. book value per shareRs62.377.0116.4137.0152.2 
Shares outstanding (eoy) m1,035.582,071.162,071.162,406.602,399.26 
Bonus/Rights/Conversions  -B1:1--- 
Price / Sales ratio x6.47.46.28.15.4 
Avg P/E ratio x24.337.837.540.621.6 
P/CF ratio (eoy) x21.933.429.734.318.6 
Price / Book Value ratio x4.86.46.17.04.6 
Dividend payout %17.49.913.74.310.7 
Avg Mkt Cap Rs m725,9421,186,7751,703,0112,294,8131,696,877 
No. of employees `00014.014.0NA14.717.5 
Total wages/salary Rs m15,34520,74445,02647,72349,023 
Avg. sales/employee Rs Th8,071.311,486.0NM19,317.218,028.3 
Avg. wages/employee Rs Th1,096.11,481.7NM3,236.12,798.8 
Avg. net profit/employee Rs Th2,130.82,243.9NM3,836.94,479.5 
SUN PHARMA INCOME DATA
Net Sales Rs m112,999160,804273,920284,870315,784 
Other income Rs m2,7632,6475,4776,5836,232 
Total revenues Rs m115,761163,451279,397291,453322,016 
Gross profit Rs m48,96272,87378,66781,583100,893 
Depreciation Rs m3,3624,09211,94710,37512,648 
Interest Rs m4324425,7905,2323,998 
Profit before tax Rs m47,93270,98666,40772,55890,479 
Minority Interest Rs m-4,863-7,375-9,36300 
Prior Period Items Rs m00-1261599 
Extraordinary Inc (Exp) Rs m-4,783-25,174-2,378-6,8520 
Tax Rs m8,4567,0229,1479,13812,116 
Profit after tax Rs m29,83131,41545,39456,58378,462 
Gross profit margin %43.345.328.728.631.9 
Effective tax rate %17.69.913.812.613.4 
Net profit margin %26.419.516.619.924.8 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m115,030186,865288,782299,413329,537 
Current liabilities Rs m28,41359,896153,294131,440178,870 
Net working cap to sales %76.779.049.559.047.7 
Current ratio x4.03.11.92.31.8 
Inventory Days Days8371768279 
Debtors Days Days7850688783 
Net fixed assets Rs m50,77158,242151,694180,477204,766 
Share capital Rs m1,0362,0712,0712,4072,399 
"Free" reserves Rs m136,274163,019278,009327,418363,997 
Net worth Rs m149,897185,250280,080329,825366,397 
Long term debt Rs m1,15348713,59831,10314,361 
Total assets Rs m205,827293,708501,601555,303614,102 
Interest coverage x112.1161.612.514.923.6 
Debt to equity ratio x0000.10 
Sales to assets ratio x0.50.50.50.50.5 
Return on assets %14.710.810.211.113.4 
Return on equity %19.917.016.217.221.4 
Return on capital %25.620.920.519.724.8 
Exports to sales %17.014.116.913.90 
Imports to sales %4.73.64.53.10 
Exports (fob) Rs m19,23822,71346,23539,5720 
Imports (cif) Rs m5,3535,77912,2298,8820 
Fx inflow Rs m19,61523,16848,70642,17144,118 
Fx outflow Rs m7,87712,62925,56421,58324,484 
Net fx Rs m11,73910,53923,14220,58819,634 
SUN PHARMA CASH FLOW
From Operations Rs m 33,566 39,592 56,157 66,859 70,822 
From Investments Rs m -26,351 -23,668 -28,657 -43,716 -42,216 
From Financial Activity Rs m -6,650 5,066 -11,865 -18,885 -22,854 
Net Cashflow Rs m 565 20,990 15,635 8,482 6,107 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.1%
FIIs 23.0%
ADR/GDR 0.0%
Free float 8.3%
Shareholders 133,026
Pledged promoter(s) holding 0.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre, Tandalja, Vadodara - 390 020
E-MAIL sunil.ajmera@sunpharma.com WEB www.sunpharma.com
TELEPHONE (022) 6696 9696 FAX (022) 2821 2010
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.7

More Pharmaceuticals Company Fact Sheets:   J.B.CHEMICALS  GSK PHARMA  CIPLA  ORCHID PHARMA LTD  GLENMARK PHARMA  

Compare SUN PHARMA With:   J.B.CHEMICALS  GSK PHARMA  CIPLA  ORCHID PHARMA LTD  GLENMARK PHARMA  

Compare SUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; IT Sector Ends 4.8% Higher(Closing)

After opening their day on a negative note, Indian share markets witnessed choppy trades and ended their session on a flat note.

Views on news

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Why India is Short of Cash Again(Vivek Kaul's Diary)

Apr 19, 2018

It is basically a supply problem with not enough currency going around in the financial system.

If Your Broker Calls You, Bang the Phone Down!(Smart Contrarian)

Apr 10, 2018

I'm going to tell you certain things about the inner workings of the industry so that you know why his advice is likely to be at best junk, and at worst dangerous.

How to Pick Great Stocks with Rajeev Thakkar(The 5 Minute Wrapup)

Apr 9, 2018

Rajeev Thakkar tells us how teachings from Vipassana can help you became a better investor.

How Small Caps Can Change the Way You Eat, Sleep, and Drive(Sector Info)

Apr 11, 2018

How you can increase your odds of seizing multibagger stocks and rake in the moolah by investing in small cap stocks.

This is How a Smart Robo-Advisor can Help You Chart Your Asset Allocation...(Outside View)

Apr 16, 2018

PersonalFN explains how a dependable robo-advisory platform can help you create your personalized asset allocation plan

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS